EDGAR Filing Documents for 0001564590-18-005311

Form 8-K - Current report:

SEC Accession No. 0001564590-18-005311

Filing Date

2018-03-12

Accepted

2018-03-12 17:00:58

Documents

Period of Report

2018-03-12

Items

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	aimt-8k_20180312.htm	8-K	28898
2	EX-99.1	aimt-ex991_7.htm	EX-99.1	259718
3	GRAPHIC	g201803122049257073501.jpg	GRAPHIC	8124
	Complete submission text file	0001564590-18-005311.txt		301188

Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884

Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220

Aimmune Therapeutics, Inc. (Filer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37519 | Film No.: 18684191
SIC: 2834 Pharmaceutical Preparations